11/22/2022
3:12 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2022
3:51 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/08/2022
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2022
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2022
6:09 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/19/2022
3:49 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/19/2022
3:45 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2022
3:35 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/06/2022
4:58 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2022
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
08/03/2022
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2022
4:10 PM | Aclaris Therapeutics (Issuer)
Manion Douglas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/02/2022
4:06 PM | Aclaris Therapeutics (Issuer)
Manion Douglas J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/01/2022
3:45 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2022
3:45 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2022
4:01 PM | Aclaris Therapeutics (Issuer)
Cawkwell Gail (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2022
3:54 PM | Aclaris Therapeutics (Issuer)
Cawkwell Gail (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2022
4:36 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2022
4:33 PM | Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2022
4:30 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2022
4:27 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2022
4:24 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2022
4:21 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2022
4:18 PM | Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2022
4:15 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2022
4:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2022
7:01 AM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2022
7:01 AM | Aclaris Therapeutics (Filer)
Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/10/2022
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2022
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2022
4:13 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/25/2022
3:30 PM | Aclaris Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G
| |
04/21/2022
6:03 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A
| |
04/21/2022
6:01 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A
| |
04/20/2022
4:06 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/13/2022
8:36 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2021
4:39 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/27/2021
3:01 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2021
6:31 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2021
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2021
4:32 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/07/2021
5:03 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2021
3:01 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2021
3:26 PM | Aclaris Therapeutics (Filer)
| Form 424B5
| |
06/08/2021
3:25 PM | Aclaris Therapeutics (Filer)
| Form 424B5
| |
06/08/2021
6:16 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2021
7:12 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
7:09 PM | Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
7:07 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
7:05 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
06/04/2021
7:02 PM | Aclaris Therapeutics (Issuer)
MILANO VINCENT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
7:00 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
6:57 PM | Aclaris Therapeutics (Issuer)
Humphries William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
6:55 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2021
6:52 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2021
4:02 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2021
8:49 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2021
8:47 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2021
8:45 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2021
8:43 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2021
8:41 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2021
3:17 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/17/2021
5:06 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/07/2021
5:28 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2021
3:45 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/07/2021
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2021
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2021
7:04 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2021
8:45 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/26/2021
8:43 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2021
6:03 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A
| |
04/22/2021
6:00 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A
| |
03/03/2021
7:42 PM | Aclaris Therapeutics (Issuer)
Gordon David N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
7:39 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
7:36 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2021
7:32 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/25/2021
6:33 AM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2021
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/11/2021
1:56 PM | Aclaris Therapeutics (Subject)
Foresite Capital Fund III, L.P. (Filed by)
| Form SC 13G/A
| |
02/11/2021
6:29 AM | Aclaris Therapeutics (Subject)
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
| Form SC 13G/A
| |
02/10/2021
5:00 PM | Aclaris Therapeutics (Issuer)
Foresite Capital Fund III, L.P. (Reporting)
Foresite Capital Fund IV, L.P. (Reporting)
Foresite Capital Fund V, L.P. (Reporting)
Foresite Capital Management III, LLC (Reporting)
Foresite Capital Management IV, LLC (Reporting)
Foresite Capital Management V, LLC (Reporting)
Tananbaum James B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/03/2021
4:33 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2021
4:29 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2021
4:26 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/03/2021
4:23 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2021
7:45 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/20/2021
4:00 PM | Aclaris Therapeutics (Filer)
| Form 424B5
| |
01/20/2021
6:18 AM | Aclaris Therapeutics (Filer)
| Form S-3MEF
| |
01/19/2021
3:04 PM | Aclaris Therapeutics (Filer)
| Form 424B5
| |
12/17/2020
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
4:07 PM | Aclaris Therapeutics (Issuer)
Ruffo Frank (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2020
4:06 PM | Aclaris Therapeutics (Issuer)
Ali-Jackson Kamil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/15/2020
6:16 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/04/2020
6:32 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2020
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/26/2020
3:49 PM | Aclaris Therapeutics (Subject)
Aclaris Therapeutics (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G
| |
09/15/2020
6:05 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/03/2020
3:23 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2020
4:18 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2020
4:28 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
